DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

DE

563.33

-4.97%↓

FDX

387.72

-1.23%↓

CTAS

175.92

-0.74%↓

FAST

44.71

-1.69%↓

DAL

68.53

+0.2%↑

Exponent Inc

Затворен

СекторИндустриални

65.9 -0.53

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

65.12

Максимум

65.9

Ключови измерители

By Trading Economics

Приходи

-3.3M

25M

Продажби

305K

147M

P/E

Средно за сектора

32.923

57.058

EPS

0.49

Дивидентна доходност

1.76

Марж на печалбата

16.796

Служители

1,212

EBITDA

-4.5M

37M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+36.61% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.76%

2.12%

Следващи печалби

30.04.2026 г.

Следваща дата на дивидент

19.06.2026 г.

Следваща дата на екс-дивидент

5.06.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-320M

3.4B

Предишно отваряне

66.43

Предишно затваряне

65.9

Настроения в новините

By Acuity

82%

18%

122 / 404 Класиране в Industrials

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Exponent Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.04.2026 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Intertek Group Rejects EQT's Revised Offer

24.04.2026 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Scoring the Cook Era -- Barrons.com

24.04.2026 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 20:50 ч. UTC

Пазарно говорене
Значими събития в новините

Financial Services Roundup: Market Talk

24.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

24.04.2026 г., 20:39 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 20:09 ч. UTC

Печалби

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24.04.2026 г., 19:48 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24.04.2026 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24.04.2026 г., 19:22 ч. UTC

Печалби

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24.04.2026 г., 19:06 ч. UTC

Печалби

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24.04.2026 г., 19:05 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24.04.2026 г., 18:30 ч. UTC

Придобивния, сливания и поглъщания

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24.04.2026 г., 18:28 ч. UTC

Придобивния, сливания и поглъщания

Intertek Rejects Revised EQT Offer

24.04.2026 г., 18:12 ч. UTC

Пазарно говорене

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24.04.2026 г., 18:06 ч. UTC

Пазарно говорене

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24.04.2026 г., 17:42 ч. UTC

Печалби

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24.04.2026 г., 17:28 ч. UTC

Печалби

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

24.04.2026 г., 17:28 ч. UTC

Пазарно говорене

Crypto Fear and Greed Index Slides Back to Neutral -- Market Talk

24.04.2026 г., 17:12 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

24.04.2026 г., 17:11 ч. UTC

Пазарно говорене

Apple Seen Gaining Market Share Despite Memory Crunch -- Market Talk

24.04.2026 г., 17:09 ч. UTC

Пазарно говорене
Печалби

Intel Seen With Stronger Long-Term Earnings Power -- Market Talk

24.04.2026 г., 17:09 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 17:06 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Correction to Advanced Micro Devices Stock Gets Upgraded to Buy. Why It's the Big Winner of Intel Earnings. -- Barrons.com

24.04.2026 г., 16:51 ч. UTC

Печалби
Придобивния, сливания и поглъщания

Two Big Loan Defaults Add to Pain in Private-Credit Funds -- WSJ

24.04.2026 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Tech, Media & Telecom Roundup: Market Talk

24.04.2026 г., 16:20 ч. UTC

Пазарно говорене
Значими събития в новините

Financial Services Roundup: Market Talk

24.04.2026 г., 16:20 ч. UTC

Пазарно говорене
Печалби

Auto & Transport Roundup: Market Talk

24.04.2026 г., 16:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Exponent Inc Прогноза

Ценова цел

By TipRanks

36.61% нагоре

12-месечна прогноза

Среден 90 USD  36.61%

Висок 95 USD

Нисък 85 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Exponent Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

4 ratings

3

Купи

1

Задържане

0

Продай

Техническа оценка

By Trading Central

75.29 / 78.99Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Weak Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

122 / 404 Класиране в Индустриални

Настроения в новините

Много силни мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Exponent Inc

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
help-icon Live chat